Skip to main content
. 2011 Jan 26;19(5):500–506. doi: 10.1038/ejhg.2010.241

Figure 1.

Figure 1

Preventive management strategies observed in BRCA1/2 mutation carriers (N=101) 5 years after test result disclosure.